|
Name |
3β,5α,9α-trihydroxy-(22E,24R)-ergosta-7,22-dien-6-one
|
Molecular Formula | C28H44O4 | |
IUPAC Name* |
17-(5,6-dimethylhept-3-en-2-yl)-3,5,9-trihydroxy-10,13-dimethyl-1,2,3,4,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-6-one
|
|
SMILES |
CC(C)C(C)C=CC(C)C1CCC2C3=CC(=O)C4(O)CC(O)CCC4(C)C3(O)CCC21C
|
|
InChI |
InChI=1S/C28H44O4/c1-17(2)18(3)7-8-19(4)21-9-10-22-23-15-24(30)28(32)16-20(29)11-12-26(28,6)27(23,31)14-13-25(21,22)5/h7-8,15,17-22,29,31-32H,9-14,16H2,1-6H3/b8-7+/t18-,19+,20-,21+,22-,25+,26+,27+,28-/m0/s1
|
|
InChIKey |
GUERPVMWCQXYEU-IHEPTZRRSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 444.66 | ALogp: | 4.8 |
HBD: | 3 | HBA: | 4 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 77.8 | Aromatic Rings: | 4 |
Heavy Atoms: | 32 | QED Weighted: | 0.52 |
Caco-2 Permeability: | -4.668 | MDCK Permeability: | 0.00001930 |
Pgp-inhibitor: | 0.105 | Pgp-substrate: | 0.012 |
Human Intestinal Absorption (HIA): | 0.029 | 20% Bioavailability (F20%): | 0.002 |
30% Bioavailability (F30%): | 0.014 |
Blood-Brain-Barrier Penetration (BBB): | 0.993 | Plasma Protein Binding (PPB): | 97.98% |
Volume Distribution (VD): | 1.462 | Fu: | 2.65% |
CYP1A2-inhibitor: | 0.011 | CYP1A2-substrate: | 0.878 |
CYP2C19-inhibitor: | 0.051 | CYP2C19-substrate: | 0.936 |
CYP2C9-inhibitor: | 0.124 | CYP2C9-substrate: | 0.064 |
CYP2D6-inhibitor: | 0.003 | CYP2D6-substrate: | 0.051 |
CYP3A4-inhibitor: | 0.841 | CYP3A4-substrate: | 0.955 |
Clearance (CL): | 9.646 | Half-life (T1/2): | 0.045 |
hERG Blockers: | 0.011 | Human Hepatotoxicity (H-HT): | 0.016 |
Drug-inuced Liver Injury (DILI): | 0.041 | AMES Toxicity: | 0.384 |
Rat Oral Acute Toxicity: | 0.621 | Maximum Recommended Daily Dose: | 0.329 |
Skin Sensitization: | 0.042 | Carcinogencity: | 0.145 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.017 |
Respiratory Toxicity: | 0.908 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC004864 | 1.000 | D0G8OC | 0.469 | ||||
ENC005610 | 1.000 | D06JPB | 0.456 | ||||
ENC003053 | 1.000 | D0G5CF | 0.448 | ||||
ENC006032 | 0.613 | D0N1TP | 0.366 | ||||
ENC004757 | 0.589 | D01QUS | 0.331 | ||||
ENC004804 | 0.589 | D08SVH | 0.323 | ||||
ENC001984 | 0.589 | D0Y7LD | 0.320 | ||||
ENC005438 | 0.589 | D0K5WS | 0.302 | ||||
ENC002324 | 0.573 | D02ZGI | 0.292 | ||||
ENC004677 | 0.573 | D0L2LS | 0.291 |